PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2813875

[Hyperprolactinemia. Reproductive consequences].

K L Austin
View original source ↗Export metadata ↓

Abstract

The medical history of 9 patients interested in childbearing are studied. They all had a high prolactin level, infertility, alteration in the menstrual cycle and in the majority (8/9) breast secretion. The results obtained with the usage of Parlodel (by the oral route) complemented with ovulation induction are evaluated, as well as existing local restrictions to permit fulfilling the various diagnostic procedures, oriented to define the etiology of the above mentioned clinical entity.

Explore related subjects

BromocriptineFemaleGalactorrheaHumansHyperprolactinemiaInfertility, FemaleLactation DisordersMenstruation DisturbancesEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K L Austin. 1989. [Hyperprolactinemia. Reproductive consequences].. https://pubmed.ncbi.nlm.nih.gov/2813875/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Postvaccinal parkinsonism.

A 5-year-old boy, with a history of fever beginning 15 days after a vaccination for measles, developed a rigid-akinetic syndrome 3 days after the fever began. A spinal tap obtained 1 week after the onset of fever showed pleocytosis with a monocellular pattern. A CT scan of the head and EEG did not disclose any abnormality. An MRI performed 3 months after the event, however, showed clear-cut evidence of bilateral substantia nigra lesions, suggesting secondary gliosis. The response to levodopa was good, but adverse reactions appeared early. The child is now 7 years old. Bromocriptine, deprenyl, and levodopa have produced a remarkable improvement of the parkinsonian features.

Bromocriptine↗
PubMed1992

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed.

Bromocriptine↗